Information Provided By:
Fly News Breaks for November 4, 2016
BCPC
Nov 4, 2016 | 13:03 EDT
Pivotal Research analyst Timothy Ramey downgraded Balchem to Sell from Hold after the company reported worse than expected earnings and revenue in Q3. The analyst cut his price target on the shares to $60 from $65.
News For BCPC From the Last 2 Days
There are no results for your query BCPC